Awake Intubation: Indications, Technique, and Sedation

Awake intubation is considered the gold standard for airway management in the anticipated difficult airway. While Rapid Sequence Induction (RSI) represents the most common approach to definitive airway management in emergency medicine, there are clinical situations in which induction of anesthesia with consecutive loss of spontaneous breathing and protective reflexes poses an unacceptable risk. In these cases, awake intubation – preserving spontaneous breathing, protective reflexes, and often consciousness – provides the safest access to the trachea. However, the technique requires meticulous preparation, adequate topical anesthesia of the airways, and titrated sedation. This article examines indications, procedural steps, and sedation protocols and provides you with a practice-oriented guide for clinical implementation.

Indications: When Is Awake Intubation the Right Choice?

The decision to perform an awake intubation is based on a structured airway evaluation. The central question is: Can I safely control the airway after induction of anesthesia – and if not, can I safely oxygenate the patient? If both questions are answered with uncertainty, awake intubation is indicated.

Classic Indications

• Known or historically difficult airway: previous difficult intubation, documented "cannot intubate" situation
• Predictors for difficult laryngoscopy AND difficult mask ventilation: combination of multiple unfavorable factors (Mallampati IV, limited mouth opening < 3 cm, short thyromental distance, limited cervical spine mobility, morbid obesity)
• Upper airway pathology: supraglottic or glottic tumors, abscesses (peritonsillar, retropharyngeal abscess), angioedema, epiglottitis, stridor
• Cervical spine instability: where manipulation of the cervical spine under anesthesia could lead to neurological damage and neurological assessment after intubation is desired
• High aspiration risk: when RSI is not justifiable due to the difficult airway, but the preserved cough reflex provides protection
• Mediastinal masses: that do not cause compression under spontaneous breathing but may lead to airway compression under positive pressure ventilation

Contraindications

Absolute contraindications for awake intubation are rare but include:

• Lack of patient cooperation: severe agitation, small children, patients unable to consent or cooperate
• Allergy to local anesthetics (all available substance classes)
• Acute airway hemorrhage that makes endoscopic visualization impossible

Relative contraindications include severe coagulopathy (bleeding risk with nasal intubation) and anatomical conditions that do not allow fiberoptic passage even under awake conditions.

Preparation: The Key to Success

An awake intubation stands or falls with preparation. Inadequate preparation leads to patient discomfort, coughing, gagging, and ultimately failure of the technique.

Patient Education and Psychological Preparation

Take time to explain the procedure to the patient in understandable terms. Key points:

• "You will stay awake, but you'll receive medication to help you relax."
• "Your throat will be numbed so you'll barely feel the tube."
• "You can breathe at all times – we won't take your air away."

Good psychological preparation significantly reduces sedation requirements and improves cooperation.

Equipment Preparation

The following equipment should be readily available:

• Flexible intubation endoscope (fiberoptic or video chip bronchoscope) with appropriate endotracheal tube (typically 6.0–7.0 mm ID)
• Alternatively: Video laryngoscope with hyperangulated blade (e.g., D-Blade, McGrath X-Blade) for video-assisted awake intubation
• Topical anesthesia: Lidocaine 2% or 4% as spray, nebulizer solution, and/or for spray-as-you-go technique
• Suction: High-powered suction, immediately ready for use
• Emergency equipment: Supraglottic airway device, surgical cricothyrotomy kit, as awake intubation can also fail
• Monitoring: Standard monitoring plus capnography, ideally High-Flow Nasal Cannula (HFNC) for apneic oxygenation
• Vasoconstrictor for nasal intubation: Xylometazoline nasal spray or naphazoline

Oxygenation

Preoxygenation and continuous oxygen delivery during awake intubation are essential. Proven methods include:

• High-Flow Nasal Cannula (HFNC) at 40–70 L/min and FiO₂ 1.0 – enables apneic oxygenation and significantly extends the safe apnea time
• Nasal cannula as a minimum standard at 5–15 L/min

Topical Anesthesia of the Airways

Topical anesthesia is the cornerstone of awake intubation. Without adequate mucosal anesthesia, the procedure is intolerable for the patient, even under deep sedation.

Airway Innervation

Understanding the innervation is relevant for topical anesthesia:

• Nasal cavity: Anterior ethmoidal nerve, posterior nasal nerves (branches of the maxillary nerve)
• Oropharynx and base of tongue: Glossopharyngeal nerve (IX)
• Supraglottic (epiglottis, aryepiglottic folds): Internal branch of the superior laryngeal nerve (branch of the vagus nerve)
• Subglottic and trachea: Recurrent laryngeal nerve (branch of the vagus nerve)

Techniques of Topical Anesthesia

Nebulization

• Inhale lidocaine 4%, 4–6 mL via a standard nebulizer (duration: approximately 15–20 minutes)
• Achieves diffuse but often insufficiently deep anesthesia of supraglottic and glottic structures
• Good as baseline anesthesia, usually requires supplementation

Spray-as-you-go Technique

• Small boluses of lidocaine 2% (1–2 mL each) are applied directly onto the vocal cords and into the trachea under direct vision via the working channel of the flexible bronchoscope
• Very effective, as anesthesia is targeted at the most reflexogenic zones
• Allow a waiting time of 30–60 seconds after each application

Oropharyngeal Spray

• Lidocaine 10% spray (e.g., Xylocaine pump spray): 3–5 sprays onto the base of tongue, palatine arches, and posterior pharyngeal wall
• Each spray delivers approximately 10 mg of lidocaine

Nerve Blocks (optional, rarely used in emergency medicine)

• Superior laryngeal nerve block: Bilaterally at the greater horn of the hyoid bone, 2 mL lidocaine 2% each – eliminates the gag reflex and supraglottic sensation
• Transtracheal injection: 2–4 mL lidocaine 2% through the cricothyroid membrane – coughing distributes the local anesthetic onto the vocal cords and tracheal mucosa

Dose Limitation

The maximum dose of lidocaine for topical application on mucous membranes is 4–5 mg/kg body weight. For a 70-kg patient, this equals 280–350 mg. Keep in mind: Absorption through the airway mucosa is nearly equivalent to intravenous administration. Always track and document the total dose. You must be familiar with signs of lidocaine toxicity (perioral tingling, metallic taste, tinnitus, seizures).

Sedation Protocols

The ideal sedation regimen for awake intubation meets the following criteria:

• Preservation of spontaneous breathing
• Anxiolysis and amnesia
• Suppression of the gag reflex (in combination with topical anesthesia)
• Good titrability
• Preservation of cooperation (patient can swallow and open mouth on command)

Dexmedetomidine – The Gold Standard

Dexmedetomidine (Precedex/Dexdor) is, based on current evidence, the most suitable sedative for awake intubation:

• Mechanism of action: α₂-agonist with sedative, anxiolytic, and analgesic properties with minimal effect on respiratory drive
• Dosing: Initial bolus 1 µg/kg over 10 minutes, followed by a maintenance infusion of 0.5–0.7 µg/kg/h
• Advantages: Cooperative sedation – patients are arousable, can follow commands, spontaneous breathing is preserved
• Disadvantages: Slow onset of action (10–15 minutes), bradycardia and hypotension possible, limited availability in some emergency departments
• Caution: Bolus can cause transient hypertension, followed by bradycardia and hypotension. Dose cautiously in hemodynamically unstable patients.

Remifentanil

• Mechanism of action: Ultra-short-acting opioid, excellently titratable
• Dosing: Target-controlled infusion (TCI) with target effect-site concentration 1.5–3 ng/mL or manual infusion 0.05–0.1 µg/kg/min
• Advantages: Excellent suppression of coughing and gag reflexes, good combination with low-dose midazolam
• Disadvantages: Respiratory depression with overdose, chest wall rigidity with rapid bolus administration, requires close monitoring
• Caution: Never administer as a bolus! Always titrate as a continuous infusion.

Midazolam + Fentanyl (Pragmatic Approach)

When neither dexmedetomidine nor remifentanil is available:

• Midazolam: 0.5–1 mg IV, fractionated every 2–3 minutes until light sedation is achieved (maximum 3–5 mg total)
• Fentanyl: 25–50 µg IV, fractionated (maximum 100–150 µg total)
• Advantages: Universally available, well-known pharmacological profile
• Disadvantages: Less titratable, higher risk of respiratory depression and loss of consciousness with overdose
• Antidotes: Flumazenil and naloxone must be readily available

Ketamine as an Alternative

• Dosing: 0.25–0.5 mg/kg IV, fractionated
• Advantages: Preservation of spontaneous breathing and protective reflexes, bronchodilatory, analgesic
• Disadvantages: Hypersalivation (administer antisialagogue beforehand: glycopyrrolate 0.2 mg IV), hallucinations, may impair cooperation
• Tip: Low-dose ketamine in combination with midazolam (to reduce psychomimetic effects) is a practical option in emergency medicine

Antisialagogues

A dry airway significantly improves both endoscopic visualization and the effectiveness of topical anesthesia:

• Glycopyrrolate: 0.2–0.4 mg IV, 15–20 minutes before the procedure
• Atropine: 0.5 mg IV as an alternative (crosses the blood-brain barrier, therefore more central side effects)

Procedure: Step by Step

Fiberoptic Awake Intubation (Nasal)

The nasal route is usually preferred for fiberoptic awake intubation, as it is technically easier and the working space does not need to be shared with the bronchoscope.

1. Vasoconstriction and local anesthesia of the nose: Xylometazoline spray in both nostrils, then place lidocaine-soaked pledgets or lidocaine gel into the chosen nasal passage. Alternatively: Carefully insert a lidocaine gel-coated nasopharyngeal airway in increasing sizes for atraumatic dilation.
2. Start sedation: Begin dexmedetomidine bolus or initiate alternative sedation protocol.
3. Topical anesthesia of the oropharynx: Oropharyngeal spray, nebulization.
4. Thread tube onto bronchoscope: Endotracheal tube (6.5–7.0 mm ID for nasal) is loaded onto the bronchoscope, connector removed.
5. Introduce the bronchoscope: Advance carefully through the prepared nasal passage. Navigate under endoscopic vision through the nasopharynx into the oropharynx.
6. Identify the glottis: Identify the epiglottis and vocal cords.
7. Spray-as-you-go: Spray 2 mL lidocaine 2% onto the vocal cords, wait 30–60 seconds.
8. Pass through the glottis: Advance the bronchoscope between the vocal cords into the trachea. Identify tracheal rings and carina for orientation.
9. Spray-as-you-go again: 2 mL lidocaine 2% intratracheally.
10. Advance the tube: Slide the endotracheal tube over the bronchoscope as a guide rail into the trachea. If resistance is encountered at the glottis: Rotate the tube 90° counterclockwise (the bevel of the tube tip is directed posteriorly).
11. Confirm position: Endoscopically verify the tube tip above the carina, withdraw the bronchoscope, connect capnography.
12. Induction of general anesthesia: Only induce general anesthesia after confirmed correct tube placement.

Video-assisted Awake Intubation (Oral)

Awake intubation with a video laryngoscope is an increasingly utilized alternative:

1. Topical anesthesia of the oropharynx: As described above, particularly thorough at the base of tongue and vallecula.
2. Sedation: As above.
3. Video laryngoscopy: Carefully insert the hyperangulated blade. Thanks to topical anesthesia, laryngoscopy is usually well tolerated.
4. Spray-as-you-go: Apply lidocaine onto the vocal cords via an atomizer or epidural catheter.
5. Intubation: Guide the tube through the glottis under direct vision using a malleable stylet (e.g., bougie) or dedicated video laryngoscope stylet.
6. Position confirmation and induction of anesthesia: As with the fiberoptic technique.

Advantage: Faster access, less equipment, shorter learning curve. Disadvantage: Less suitable for supraglottic pathologies that obscure the direct line of sight.

Complications and Pitfalls

• Respiratory depression from oversedation: The most common and most dangerous error. Always titrate, never bolus (exception: low-dose midazolam). Pulse oximetry and capnography are mandatory.
• Inadequate topical anesthesia: Leads to coughing, laryngospasm, and procedural failure. It's better to invest more time in topical anesthesia.
• Epistaxis (with nasal route): Use atraumatic technique, adequate vasoconstriction, and lubricant.
• Lidocaine toxicity: Document total dose, do not exceed maximum dose. When in doubt, have Intralipid 20% readily available.
• Aspiration: Theoretically possible despite preserved protective reflexes, especially under deep sedation. Have suction ready.
• Failure of awake intubation: Must be considered as a possibility in the planning. Define backup strategies (surgical airway, allow the patient to wake up, alternative technique) in advance.

Documentation and Team Communication

Before starting the awake intubation, a structured team briefing should take place:

• Plan A: Awake intubation (fiberoptic or video laryngoscopic)
• Plan B: Alternative technique if Plan A fails (e.g., switch from oral to nasal or vice versa)
• Plan C: Abort, allow the patient to wake up, surgical airway
• Role assignment: Who intubates, who sedates and monitors, who manages suction, who performs cricothyrotomy in an emergency

Documentation of a successful or failed awake intubation is essential for future airway management decisions. Use a difficult airway alert card or an institutional documentation system.

Practical Training

Awake intubation is one of the most demanding techniques in airway management. Theoretical knowledge alone is not sufficient – topical anesthesia, titrated sedation, and endoscopic navigation require hands-on practice under realistic conditions. In the ACLS courses offered by Simulation Tirol, you train structured airway management, including decision-making in the difficult airway, in an AHA-certified setting with high-fidelity simulation. The combination of algorithm training, hands-on exercises, and realistic scenarios gives you the confidence you need for critical airway situations.